Publicacions en col·laboració amb investigadors/es de Hospital Universitario 12 de Octubre (39)

2024

  1. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  2. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

  2. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  3. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  4. Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation

    Heart, Vol. 109, Núm. 18, pp. 1401-1406

2022

  1. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Prognostic value of 3D area strain in moderate or severe aortic regurgitation with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 805-807

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. A genetic risk score predicts recurrent events after myocardial infarction in young adults

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 623-631

  3. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  4. Differences between cardiologists’ perceptions and clinical reality of the quality of anticoagulation with vitamin K antagonists in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 332-334

  5. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

  6. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 985-993

  7. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. Access to INR and times for prescribing direct oral anticoagulants in patients treated with vitamin K antagonists in cardiology clinics in Spain

    REC: CardioClinics, Vol. 54, Núm. 4, pp. 231-238

  3. Current status of anticoagulation in patients with breast cancer and atrial fibrillation

    Breast, Vol. 46, pp. 163-169

  4. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Gastroenterology, Vol. 157, Núm. 1, pp. 74-86.e15